Medicine and medications are based more around profits than they are results in the United States

There have never been any confirmed cases of psilocybin mushrooms being associated with fatalities other than individuals taking the wrong type of mushroom by mistake which would never occur within a medical context. https://www.erowid.org... Although the FDA receives funding from pharmaceutical companies, there are still some sanctions on which drugs are allowed to be administered to the public and thus, must undergo testing. That being said, it doesn't prevent the testing to be biased towards specific drugs depending on where those drugs are coming from and how quickly the testing of said drugs can be completed. The Prescription Drug User Fee Act which authorizes drug companies to pay "user fees" to the FDA for drugs considered for approval is a prime example of this. The money generated by this act has been earmarked to speed up the approval process for said drugs. The part of the agency that reviews new drugs gets over half of its money from these user fees, and as a result, the companies that are very literally paying the FDA get an inherent bias in the testing procedures. The companies that pay these fees have their drugs tested more expediently and the drugs get to market more quickly (Marcia Angell, M.D.). Antineoplaston therapy was undergoing testing by the FDA back in the 1990's and the trials were sabotaged. Of the 9 patients included in the trial, none of the patients received the proper amount of antineoplaston therapy recommended by Dr. Burzynski and some of them received no treatment at all. The trials were also closed prior to completion and the statement "no conclusion can be made about the effectiveness or toxicity of antineoplastons" was published in association with the trials. In 1999, a year later, the NCI cited antineoplaston therapy as a "complete failure" in literature. So, while it is true that the FDA does still somewhat do its job to verify that medicine actually works, it does so in a biased way that favors companies and corporations that yield more profit. This bias shows that the profit is more important than the results gained for the public in finding medications that work well and can help individuals heal. "Besides, if these methods worked, the companies would have been using this method, so that they could keep the cancer patients alive and make them pay for more drugs, right?" -Wrong. The companies wouldn't stand to gain any profit because they don't have any patents on the antineoplaston therapy. It is true that they could keep more cancer patients alive using this therapy and the patients may have to spend more money on the drugs... but that's not the issue. The issue is where that money would be going to which would no longer be the NCI or the pharmaceutical companies that currently handle the manufacturing of cancer medications. As I already cited in my previous argument, Dr. Richard Crout, Director of the FDA Bureau of Drugs, once wrote in a 1982 newsletter: "I never have and never will approve a new drug to an individual, but only to a large pharmaceutical firm with unlimited finances." -It's not about how much profit could be managed using the antineoplaston therapy but about where those profits would go. The cancer industry is an enormous source of profit for pharmaceutical companies and to introduce a new method of treatment that would make prior methods of treatment worthless would be an enormous blow to these companies. As a result, many forms of sabotage have been used to keep these drugs from the publics' hands. The question here isn't whether or not the FDA and the U.S. government has any interest in providing the public with medications that work, but which is more important to them between profits and health. The inherent bias in the industry that allows pharmaceutical companies to pay the very institution that monitors and evaluates them is a clear indicator that profits outweigh ethics and good medical practice within their minds.